InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the complete record of transactions filed by ROBERTSON MICHELLE, Chief Financial Officer. Director active across 1 companies, notably Editas Medicine, Inc.. Aggregated, 12 reports have been recorded. Total volume traded: €107k. The latest transaction was disclosed on 3 June 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations12 total
€16,3861,527 shares@ €10.73090.0082% mcap4.5% of flow
Common Stock
SEC:0001415889-22-006161:0·
€11,960767 shares@ €15.59320.0060% mcap3.3% of flow
Common Stock
SEC:0001415889-22-002655:0·
053,499 shares0
Common Stock
SEC:0001415889-22-001223·
053,499 shares0
Common Stock
SEC:0001415889-22-001223:0·
€39,5581,744 shares@ €22.68230.020% mcap23.4% of flow
Common Stock
SEC:0001179110-22-000470·
€39,5581,744 shares@ €22.68230.020% mcap10.8% of flow
Common Stock
SEC:0001179110-22-000470:0·
04,471 shares0
Common Stock
SEC:0001179110-21-011224·
04,471 shares0
Common Stock
SEC:0001179110-21-011224:0·
€65,2772,500 shares@ €26.11070.033% mcap38.6% of flow
Common Stock
SEC:0001179110-21-008086·
€65,2772,500 shares@ €26.11070.033% mcap17.8% of flow
Common Stock
SEC:0001179110-21-008086:0·
€64,2352,500 shares@ €25.69390.032% mcap38.0% of flow
Common Stock
SEC:0001179110-21-007175·
€64,2352,500 shares@ €25.69390.032% mcap17.5% of flow
Common Stock
SEC:0001179110-21-007175:0·
12 of 12 declarations
About ROBERTSON MICHELLE
ROBERTSON MICHELLE is the Chief Financial Officer at Editas Medicine, Inc. She is responsible for the financial management of the company, including financial planning and regulatory compliance, contributing to the financial health of the organization.
